Weibo Du
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Liver physiology and pathology
- Hepatitis C virus research
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Hepatology 15
- Liver physiology and pathology 6
- Liver Disease and Transplantation 6
- Surgery 11
- Organ Transplantation Techniques and Outcomes 7
- Pancreatic function and diabetes 4
- Co-authors
- Lanjuan Li (15 shared papers)Xiaoping Pan (10 shared papers)Hongcui Cao (10 shared papers)Wenbiao Chen (4 shared papers)Chengbo Yu (6 shared papers)Jianrong Huang (3 shared papers)Yu Liang (1 shared paper)Yuemei Chen (3 shared papers)
- Journals
- Journal of Hepatology (3 papers)Biotechnology and Bioengineering (1 paper)International Journal of Medical Sciences (1 paper)Smart Materials and Structures (1 paper)Biotechnology Letters (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Weibo Du
31 papers receiving 528 citations
Peers
Comparison fields: 5 of 97
- Hepatology 258
- Pharmacology 61
- Epidemiology 206
- Cancer Research 61
- Biological Psychiatry 8
Countries citing papers authored by Weibo Du
This map shows the geographic impact of Weibo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Du more than expected).
Fields of papers citing papers by Weibo Du
This network shows the impact of papers produced by Weibo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Du. The network helps show where Weibo Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Weibo Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 50 | |
| 2 | 2020 | 47 | |
| 3 | 2013 | 43 | |
| 4 | 2011 | 38 | |
| 5 | 2009 | 34 | |
| 6 | 2011 | 30 | |
| 7 | 2014 | 29 | |
| 8 | Prognostic models for acute liver failure. | 2010 | 27 |
| 9 | 2024 | 26 | |
| 10 | 2014 | 24 | |
| 11 | 2015 | 23 | |
| 12 | 2007 | 21 | |
| 13 | 2016 | 18 | |
| 14 | 2010 | 17 | |
| 15 | 2012 | 14 | |
| 16 | 2022 | 14 | |
| 17 | 2015 | 13 | |
| 18 | 2020 | 13 | |
| 19 | 2018 | 10 | |
| 20 | 2019 | 10 |
About Weibo Du
Weibo Du is a scholar working on Hepatology, Surgery, Epidemiology, Molecular Biology and Cancer Research, having authored 32 papers that have together received 546 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Organ Transplantation Techniques and Outcomes (7 papers), Liver physiology and pathology (6 papers), Liver Disease and Transplantation (6 papers), Pancreatic function and diabetes (4 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Hepatology (258 citations), Pharmacology (61 citations), Epidemiology (206 citations), Cancer Research (61 citations) and Biological Psychiatry (8 citations). Weibo Du has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lanjuan Li, Xiaoping Pan, Hongcui Cao, Wenbiao Chen, Chengbo Yu, Jianrong Huang, Yu Liang, Yuemei Chen, Minglin Ou and Yong Dai. Their work appears in journals such as Journal of Hepatology, Biotechnology and Bioengineering, International Journal of Medical Sciences, Smart Materials and Structures and Biotechnology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.